Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Atrion Corporation is 'Cautious Hold'. Macroaxis provides Atrion buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Atrion positions. The advice algorithm takes into account all of Atrion available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Atrion buy-and-hold prospective. Check also Atrion Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon Atrion Corporation has a mean deviation of 0.9922, semi deviation of 0.9343, standard deviation of 1.43, variance of 2.03, downside variance of 1.51 and semi variance of 0.8728Macroaxis provides buy, hold, or sell suggestion on Atrion to complement and cross-verify current analyst consensus on Atrion Corporation. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Atrion is not overpriced, please confirm all Atrion fundamentals including its Price to Sales, Cash Flow from Operations, Current Liabilities, as well as the relationship between Cash and Equivalents and Market Capitalization . Given that Atrion has Number of Shares Shorted of 44.77K, we suggest you validate Atrion Corporation market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Atrion Trading Alerts and Improvement Suggestions
About 62.0% of the company shares are held by institutions such as insurance companies
Atrion Corporation has relatively low volatility with skewness of 0.87 and kurtosis of 2.45. However, we advise all investors to independently investigate Atrion Corporation to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.